Page last updated: 2024-08-22

trimetazidine and endothelin-1

trimetazidine has been researched along with endothelin-1 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allibardi, S; Chierchia, S; Costa, S; Monti, LD; Piatti, PM; Pozza, G; Samaja, M; Valsecchi, G1
Calori, G; Chierchia, S; Fragasso, G; Lu, C; Margonato, A; Monti, L; Palloshi, A; Piatti, PM; Pozza, G; Setola, E; Valsecchi, G1
Camisasca, RP; Fragasso, G; Galluccio, E; Lucotti, P; Margonato, A; Monti, LD; Origgi, A; Piatti, P; Setola, E1
Aksoy, Y; Akturk, E; Barutcu, I; Cehreli, S; Ozdemir, R; Sincer, I; Topal, E1
Dong, XD; Hu, DY; Jia, SQ; Wang, L; Yan, SB1

Trials

4 trial(s) available for trimetazidine and endothelin-1

ArticleYear
Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.
    Journal of the American College of Cardiology, 2002, Feb-06, Volume: 39, Issue:3

    Topics: Aged; Analysis of Variance; Anticoagulants; Biomarkers; Blood Pressure; Coronary Artery Disease; Double-Blind Method; Electrocardiography; Endothelin-1; Exercise Test; Fatty Acids, Nonesterified; Heart Rate; Heparin; Humans; Lactic Acid; Male; Middle Aged; Nitric Oxide; Sensory Thresholds; Treatment Outcome; Trimetazidine; Vasodilator Agents

2002
Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy.
    American journal of physiology. Endocrinology and metabolism, 2006, Volume: 290, Issue:1

    Topics: 3-Hydroxybutyric Acid; Aged; Blood Glucose; Citric Acid; Cross-Over Studies; Cyclic GMP; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Fatty Acids, Nonesterified; Forearm; Glucose; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Muscle, Skeletal; Myocardial Ischemia; Oxidation-Reduction; Trimetazidine

2006
The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
    Journal of electrocardiology, 2006, Volume: 39, Issue:2

    Topics: Blood Flow Velocity; Chi-Square Distribution; Coronary Angiography; Coronary Disease; Coronary Vessels; Double-Blind Method; Electrocardiography, Ambulatory; Endothelin-1; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nitric Oxide; Regional Blood Flow; Statistics, Nonparametric; Trimetazidine; Vasodilator Agents

2006
[Clinical study of trimetazidine for myocardial protection in acute myocardial infarction].
    Zhonghua nei ke za zhi, 2007, Volume: 46, Issue:8

    Topics: Aged; Endothelin-1; Follow-Up Studies; Humans; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Trimetazidine; Vasodilator Agents

2007

Other Studies

1 other study(ies) available for trimetazidine and endothelin-1

ArticleYear
Triglycerides impair postischemic recovery in isolated hearts: roles of endothelin-1 and trimetazidine.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 281, Issue:3

    Topics: Animals; Dose-Response Relationship, Drug; Endothelin-1; Glucose; Heart Rate; Hyperglycemia; Hyperinsulinism; In Vitro Techniques; Insulin; Male; Myocardial Ischemia; Myocardial Reperfusion; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Recovery of Function; Reperfusion Injury; Triglycerides; Trimetazidine; Vasodilator Agents; Ventricular Function, Left

2001